Literature DB >> 18752950

Trace amine-associated receptor 1 (TAAR1) is activated by amiodarone metabolites.

Aaron N Snead1, Motonori Miyakawa, Edwin S Tan, Thomas S Scanlan.   

Abstract

Amiodarone (Cordarone, Wyeth-Ayerst Pharmaceuticals) is a clinically available drug used to treat a wide variety of cardiac arrhythmias. We report here the synthesis and characterization of a panel of potential amiodarone metabolites that have significant structural similarity to thyroid hormone and its metabolites the iodothyronamines. Several of these amiodarone derivatives act as specific agonists of the G protein-coupled receptor (GPCR) trace amine-associated receptor 1 (TAAR(1)). This result demonstrates a novel molecular target for amiodarone derivatives with potential clinical significance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18752950      PMCID: PMC3609712          DOI: 10.1016/j.bmcl.2008.08.013

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  15 in total

1.  Towards an animal model of amiodarone-induced thyroid dysfunction.

Authors:  W M Wiersinga
Journal:  Eur J Endocrinol       Date:  1997-07       Impact factor: 6.664

2.  Amiodarone and thyroid hormone metabolism.

Authors:  W M Wiersinga; M D Trip
Journal:  Postgrad Med J       Date:  1986-10       Impact factor: 2.401

3.  Trace amine-associated receptor agonists: synthesis and evaluation of thyronamines and related analogues.

Authors:  Matthew E Hart; Katherine L Suchland; Motonori Miyakawa; James R Bunzow; David K Grandy; Thomas S Scanlan
Journal:  J Med Chem       Date:  2006-02-09       Impact factor: 7.446

4.  Amiodarone reduces the effect of T3 on beta adrenergic receptor density in rat heart.

Authors:  R Hartong; W M Wiersinga; T A Plomp
Journal:  Horm Metab Res       Date:  1990-02       Impact factor: 2.936

5.  Interaction of amiodarone and desethylamiodarone with solubilized nuclear thyroid hormone receptors.

Authors:  K R Latham; D F Sellitti; R E Goldstein
Journal:  J Am Coll Cardiol       Date:  1987-04       Impact factor: 24.094

6.  Exploring the structure-activity relationship of the ethylamine portion of 3-iodothyronamine for rat and mouse trace amine-associated receptor 1.

Authors:  Edwin S Tan; Motonori Miyakawa; James R Bunzow; David K Grandy; Thomas S Scanlan
Journal:  J Med Chem       Date:  2007-05-12       Impact factor: 7.446

7.  3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone.

Authors:  Thomas S Scanlan; Katherine L Suchland; Matthew E Hart; Grazia Chiellini; Yong Huang; Paul J Kruzich; Sabina Frascarelli; Dane A Crossley; James R Bunzow; Simonetta Ronca-Testoni; Emil T Lin; Daniel Hatton; Riccardo Zucchi; David K Grandy
Journal:  Nat Med       Date:  2004-05-16       Impact factor: 53.440

8.  Pharmacokinetics and body distribution of amiodarone in man.

Authors:  T A Plomp; J M van Rossum; E O Robles de Medina; T van Lier; R A Maes
Journal:  Arzneimittelforschung       Date:  1984

9.  Desethylamiodarone is a competitive inhibitor of the binding of thyroid hormone to the thyroid hormone alpha 1-receptor protein.

Authors:  H C van Beeren; O Bakker; W M Wiersinga
Journal:  Mol Cell Endocrinol       Date:  1995-07       Impact factor: 4.102

10.  Desethylamiodarone is a noncompetitive inhibitor of the binding of thyroid hormone to the thyroid hormone beta 1-receptor protein.

Authors:  O Bakker; H C van Beeren; W M Wiersinga
Journal:  Endocrinology       Date:  1994-04       Impact factor: 4.736

View more
  10 in total

1.  Structural and functional evolution of the trace amine-associated receptors TAAR3, TAAR4 and TAAR5 in primates.

Authors:  Claudia Stäubert; Iris Böselt; Jens Bohnekamp; Holger Römpler; Wolfgang Enard; Torsten Schöneberg
Journal:  PLoS One       Date:  2010-06-15       Impact factor: 3.240

2.  Determinants involved in subtype-specific functions of rat trace amine-associated receptors 1 and 4.

Authors:  C Stäubert; J Bohnekamp; T Schöneberg
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

Review 3.  Trace amine-associated receptors as emerging therapeutic targets.

Authors:  Tatyana D Sotnikova; Marc G Caron; Raul R Gainetdinov
Journal:  Mol Pharmacol       Date:  2009-04-23       Impact factor: 4.436

Review 4.  Minireview: 3-Iodothyronamine (T1AM): a new player on the thyroid endocrine team?

Authors:  Thomas S Scanlan
Journal:  Endocrinology       Date:  2008-12-30       Impact factor: 4.736

5.  Amiodarone and its putative metabolites fail to activate wild type hTAAR1.

Authors:  Anita H Lewin; Hernán A Navarro; Brian P Gilmour
Journal:  Bioorg Med Chem Lett       Date:  2009-08-20       Impact factor: 2.823

6.  Differential modulation of Beta-adrenergic receptor signaling by trace amine-associated receptor 1 agonists.

Authors:  Gunnar Kleinau; Juliane Pratzka; Daniela Nürnberg; Annette Grüters; Dagmar Führer-Sakel; Heiko Krude; Josef Köhrle; Torsten Schöneberg; Heike Biebermann
Journal:  PLoS One       Date:  2011-10-31       Impact factor: 3.240

7.  Warfarin-amiodarone drug-drug interactions: determination of [I](u)/K(I,u) for amiodarone and its plasma metabolites.

Authors:  M G McDonald; N T Au; A K Wittkowsky; A E Rettie
Journal:  Clin Pharmacol Ther       Date:  2012-03-07       Impact factor: 6.875

8.  Genetic Polymorphisms Affect Mouse and Human Trace Amine-Associated Receptor 1 Function.

Authors:  Xiao Shi; Nicole A R Walter; John H Harkness; Kim A Neve; Robert W Williams; Lu Lu; John K Belknap; Amy J Eshleman; Tamara J Phillips; Aaron Janowsky
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

9.  Visible-light-induced oxidant and metal-free dehydrogenative cascade trifluoromethylation and oxidation of 1,6-enynes with water.

Authors:  Sadhan Jana; Ajay Verma; Rahul Kadu; Sangit Kumar
Journal:  Chem Sci       Date:  2017-07-10       Impact factor: 9.825

10.  Tungstate-Catalyzed Biomimetic Oxidative Halogenation of (Hetero)Arene under Mild Condition.

Authors:  Zhuang Ma; Helin Lu; Ke Liao; Zhilong Chen
Journal:  iScience       Date:  2020-04-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.